Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetrahydrodeoxycorticosterone (THDOC) is an endogenous neurosteroid derived from deoxycorticosterone. It is synthesized in the brain and adrenal glands and acts as a potent positive allosteric modulator of GABA_A receptors, conferring sedative, anxiolytic, and anticonvulsant effects. THDOC levels fluctuate during stress and hormonal changes, and are implicated in various neurological and psychiatric conditions.
Positive allosteric modulation of GABA_A receptors, enhancing GABAergic neurotransmission.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetrahydrodeoxycorticosterone (THDOC).